Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Genes associated with T helper 17 cell differentiation and function.
“Veterinary Medicines” page
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
Avonex approval application
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Estrogen and testosterone therapies in multiple sclerosis.
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
Cuprizone neurotoxicity in the rat: morphologic observations.
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Pages